Tag: biotech
-
![Did Aytu BioScience (AYTU.Q) just SpankChain the NASDAQ?]()
Did Aytu BioScience (AYTU.Q) just SpankChain the NASDAQ?
When a sector gets hot, small cap stocks can often get a bump by sidling up to the hot sector with a new product/idea/opportunity. When the dust clears, the intrinsic value of the new offering is typically deemed to be low. We saw it in 3D-printing, with Dung Beetle Treats. We saw it in weed…
-
![CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine]()
CloudMD (DOC.C): Perhaps this might be a good time to talk about investing in telemedicine
As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold…
-
Moderna’s (MRNA.Q) “Coronavirus Vaccine” announcement – causes $3.4 billion jump in market cap
We’ll take a wild guess that precisely NONE of the retail investors who just drove up the price of the MRNA would recognise a “stabilized form of S protein” if they met it on a beach, made sand castles with it – then took it home to play Spin-The-Bottle.
-
![Resverlogix (RVX.T), Sirona Biochem (SBM.V), Sernova (SVA.V): 3 Canadian biotechs tackle a $330 billion health crisis]()
Resverlogix (RVX.T), Sirona Biochem (SBM.V), Sernova (SVA.V): 3 Canadian biotechs tackle a $330 billion health crisis
A Harvard University Study calculates the economic burden from diabetes at about $1.3 trillion, or 1.8% of global GDP.
-
![BioTech Breakthrough: why is Greenpeace turning its back on 350,000 blind children?]()
BioTech Breakthrough: why is Greenpeace turning its back on 350,000 blind children?
With offices in 41 countries, 2.8 million members and a patriarchal structure, Greenpeace has global revenue of USD $300 million. Its most successful fundraising catalysts have been images of beautiful animals about to be slaughtered.
-
![ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s]()
ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s
Someone in the world develops dementia every three seconds. Alzheimer’s disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to 131.5M by 2050, that is, unless companies like ProMis Neurosciences (PMN.T) can do the unthinkable. See, our understanding of Alzheimer’s has changed dramatically since its discovery…
